Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pleomorphic giant cell carcinoma of prostate: Rare tumor with unique clinicopathological, immunohistochemical, and molecular features.

Annals of diagnostic pathology - 1 Jun 2021

El-Zaatari Ziad M, Thomas Jessica S, Divatia Mukul K, Shen Steven S, Ayala Alberto G, Monroig-Bosque Paloma, Shehabeldin Ahmed, Ro Jae Y

Abstract excerpt

Pleomorphic giant cell carcinoma (PGCC) of the prostate is a rare entity categorized as a variant of prostatic acinar adenocarcinoma in the 2016 World Health Organization (WHO) classification system. PGCC differs from conventional prostatic adenocarcinoma by having bizarre, markedly enlarged, and pleomorphic cells. It differs from high grade urothelial carcinoma by negativity for urothelial differentiation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Dedifferentiation
Share to Class I Phosphatidylinositol 3-Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diagnosis, Differential

Share to Homeodomain Proteins

Share to Neoplasm Grading

Share to Prostatic Neoplasms

Share to Urinary Bladder Neoplasms

Share to Urothelium

Source

Identifiers

PMID: 33640702
DOI: 10.1016/j.anndiagpath.2021.151719

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pleomorphic giant cell carcinoma of prostate: Rare tumor with unique clinicopathological, immunohistochemical, and molecular features.PMID 33640702Read ↗

Prostatic cancers: understanding their molecular pathology and the 2016 WHO classificationSemantic proximity Read ↗

Understanding Polyploid Giant Cancer Cells: From Molecular Mechanisms to Clinical ImplicationsSemantic proximity Read ↗

Neuroendocrine Prostate Cancer: Subtypes, Biology, and Clinical OutcomesSemantic proximity Read ↗

Prostate Adenocarcinoma with Signet-Ring Cells and Features of Mucin. A Clinical Case and Literature ReviewSemantic proximity Read ↗

Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate CancerSemantic proximity Read ↗

Clinicopathological features to distinguish malignant solitary fibrous tumors of the prostate from prostatic stromal tumors.Semantic proximity Read ↗

Genomic analysis of bladder urothelial carcinoma with osteoclast‑like giant cells: A case reportSemantic proximity Read ↗

Solitary Fibrous tumor of Urinary Bladder with carcinoma prostate – Dual malignancy the diagnostic and management challenges involved: A Rare case reportSemantic proximity Read ↗

Phenotypic appearances of prostate utilizing PET-MRI and PET-CT with 68Ga-PSMA, radiolabelled choline and 68Ga-DOTATATE.Semantic proximity Read ↗

[Neuroendocrine prostate cancer: Natural history, molecular features, therapeutic management and future directions].Semantic proximity Read ↗

Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma.Semantic proximity Read ↗

Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas harboring KRAS and BRCA mutations: case report and whole exome sequencing analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.